Neovacs

Neovacs EBIT per Share

The EBIT per Share of Neovacs (ALNEV.PA) as of Oct 14, 2026 is -33,108.50 EUR. In the previous year, EBIT per Share was -1,222.40 EUR — a change of 2,608.48% (lower).

EBIT per Share

-33,108.50EUR

YoY

2,608.48%

Last updated:

EBIT per Share of Neovacs is 2024 -33,108.50 EUR. EBIT per Share of Neovacs was 2023 -1,222.40 EUR. It decreases by 2,608.48% lower compared to the previous year.

The Neovacs EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2012
-0.50 EUR
Jan 1, 2013
-0.45 EUR
Jan 1, 2014
-0.41 EUR
Jan 1, 2015
-3,524.59 EUR
Jan 1, 2016
-3,923.05 EUR
Jan 1, 2017
-2,656.43 EUR
Jan 1, 2018
-1,222.40 EUR
Jan 1, 2024
-33,108.50 EUR
The Neovacs EBIT per Share history
YEAREBIT per ShareYoY
-33,108.50EUR+2,608.48%
-1,222.40EUR-53.98%
-2,656.43EUR-32.29%
-3,923.05EUR+11.30%
-3,524.59EUR+856,368.80%
-0.41EUR-7.80%
-0.45EUR-10.25%
-0.50EUR-19.49%
-0.62EUR+2.31%
-0.60EUR+19.81%
-0.50EUR+58.41%
-0.32EUR+1.54%
-0.31EUR—
Access this data via the Eulerpool API
Get Free API Key

Neovacs Stock analysis

What does Neovacs do? Neovacs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neovacs stock

EBIT per Share of Neovacs is -33,108.50 EUR in 2024.

EBIT per Share of Neovacs changed from -1,222.40 EUR to -33,108.50 EUR, representing a 2,608.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Neovacs since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Neovacs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Neovacs